The US FDA has made some public amendments to PMI’s reduced risk applications for IQOS and three types of Marlboro HeatSticks products…
Author: Daniel Mollenkamp
-
-
Uncertainty hangs over PMI application as FDA misses its own deadline
Written by Daniel Mollenkamp | 9th October 2017 | News analysis
The US FDA has missed its own 180-day deadline for replying to the premarket tobacco application (PMTA) by Philip Morris International for its IQOS heated tobacco products…
-
American Vaping Association urges FDA to approve iQOS
Written by Daniel Mollenkamp | 14th September 2017 | News analysis
The American Vaping Association has written to FDA commissioner Scott Gottlieb urging him to approve PMI’s heated tobacco product iQOS for sale in the US…
-
PMI’s iQOS enters FDA process, edging closer to U.S. launch
Written by Daniel Mollenkamp | 3rd April 2017 | News analysis
Philip Morris International (PMI) has submitted its iQOS heat-not-burn system for approval by the U.S. Food and Drug Administration (FDA)….